Jazz Pharmaceuticals PLC: JP Morgan raises target price to $300 from $276
JAZZ•JP Morgan raised its target price for Jazz Pharmaceuticals to $300 from $276.
Related News
Nutanix sees retail IT under pressure as store demands grow, budgets lag
NTNX•
TD Cowen raises Beta Bionics target price to $21 from $18
BBNX•
South Korea media commission fines Google and Apple over app payment systems
AAPL•
Nasdaq trade halt continues; reason not available at 3:58 a.m.
HCHL•
Japan's Nikkei rises as tech results revive AI optimism; Topix sags
EWJ•